These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22052653)

  • 1. Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    J Pharm Sci; 2012 Feb; 101(2):530-40. PubMed ID: 22052653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of a PAMPA model to predict passive gastrointestinal absorption and plasma protein binding.
    Bujard A; Voirol H; Carrupt PA; Schappler J
    Eur J Pharm Sci; 2015 Sep; 77():273-8. PubMed ID: 26118348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique.
    Bujard A; Sol M; Carrupt PA; Martel S
    Eur J Pharm Sci; 2014 Oct; 63():36-44. PubMed ID: 25008117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A; Alves G; Falcão A; Soares-da-Silva P
    Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the Passive Intestinal Absorption of Medicinal Plant Extract Constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA).
    Petit C; Bujard A; Skalicka-Woźniak K; Cretton S; Houriet J; Christen P; Carrupt PA; Wolfender JL
    Planta Med; 2016 Mar; 82(5):424-31. PubMed ID: 26872320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Cassette PAMPA for Permeability Screening.
    Oh MH; Lee HJ; Jo SH; Park BB; Park SB; Kim EY; Zhou Y; Jeon YH; Lee K
    Biol Pharm Bull; 2017; 40(4):419-424. PubMed ID: 28381797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
    Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
    Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique.
    Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL
    Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
    Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells.
    Rastogi H; Jana S
    Eur J Drug Metab Pharmacokinet; 2016 Feb; 41(1):33-43. PubMed ID: 25351179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDM-PAMPA to predict gastrointestinal absorption, binding percentage, equilibrium and kinetics constants with human serum albumin and using 2 end-point measurements.
    Bujard A; Petit C; Carrupt PA; Rudaz S; Schappler J
    Eur J Pharm Sci; 2017 Jan; 97():143-150. PubMed ID: 27816629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.